Refine Your Results

Click below to filter your search results

"Medications or Drugs"Undo

Results 101–125 of 132

Title Date
101.

ACOG Statement on Single-Dose EC Reformulation

Washington, DC -- The US Food and Drug Administration's (FDA) approval of a new one-pill formulation of the emergency contraceptive Plan B® represents a positive step forward for women's health, ...

July 2009

102.

ACOG Launches New Menopause Website

Washington, DC -- The American College of Obstetricians and Gynecologists (ACOG) has launched a new website devoted to women who are approaching or going through menopause to provide them with the ne...

June 2009

103.

Bad Economy Blamed for Women Delaying Pregnancy and Annual Check-Up

Chicago, IL -- As a result of the economy, women are delaying pregnancy as well as their annual well-woman exam, according to a new Gallup Organization survey conducted for The American College of Ob...

May 2009

104.

Optimal Goals for Anesthesia Care in Obstetrics

Number 433

(Replaces No. 256, May 2001)

ABSTRACT: A joint statement from the American Society of Anesthesiologists and the American College of Obstetricians and Gynecologists was developed to address issues of concern to both specialties. ...

May 2009

PDF Download
105.

ACOG Lauds Court Decision Regarding Emergency Contraception

Washington, DC -- The American College of Obstetricians and Gynecologists (ACOG) lauds the recent ruling by the Federal District Court in New York ordering the US Food and Drug Administration (FDA) t...

April 2009

106.

Los fibromas uterinos

SP074

Los fibromas uterinos son tumores benignos (no cancerosos) en el utero. Estos tumores son el tipo mas comun de tumor que aparece en la pelvis de la mujer. En algunas mujeres, los fibromas permanecen ...

April 2009

107.

ACOG Reiterates Stance on So-Called "Bioidentical" Hormones

Washington, DC -- In response to recent media attention being given to so-called bioidentical hormones, The American College of Obstetricians and Gynecologists (ACOG) reiterates its position that the...

February 2009

108.

Misoprostol for Postabortion Care

Number 427

ABSTRACT: The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a ...

February 2009

PDF Download
109.

ACOG Urges Wider Availability of Misoprostol Internationally to Reduce Maternal Mortality

Washington, DC -- Misoprostol is a safe and cost-effective way to provide women with postabortion care services, especially in less developed countries where obstacles to timely health care remain an...

January 2009

110.

Substance Abuse - A Fact Sheet for Parents

FS033

What is meant by substance abuse? Use of any illegal drug, such as cocaine, marijuana, or heroin, Any use of alcohol or tobacco (see the “Tobacco Use” and “Alcohol Use” fact sheets) that causes risk...

January 2009

PDF Download
111.

Substance Abuse

FS024

What is meant by substance abuse? Any use of an illegal drug such as cocaine, marijuana, or heroin Any use of alcohol or tobacco (see the “Tobacco Use” and “Alcohol Use” fact sheets) that causes ris...

January 2009

PDF Download
112.

Menstrual Cramps and Dysmenorrhea

FS015

What causes menstrual cramps? When most girls begin their menstrual cycles, muscle cramps in the uterus are caused by contractions that lead to discomfort and pain. The body produces a chemical call...

January 2009

PDF Download
113.

Bone Mineral Density Concerns Should Not Discourage Use of Contraceptive Shot

Washington, DC -- Concerns about the effects of depot medroxyprogesterone acetate (DMPA)—the contraceptive shot—on bone mineral density (BMD) should not prevent clinicians from prescribin...

September 2008

114.

Aromatase Inhibitors in Gynecologic Practice

Number 412

(Reaffirmed 2012)

ABSTRACT: Aromatase inhibitors appear to be effective as an adjuvant treatment for early-stage and late-stage breast cancer. Their role in chemoprevention of breast cancer in high-risk patients remai...

August 2008

PDF Download
115.

Tabaco, alcohol, drogas y embarazo

SP170

Cuando esta embarazada, todo lo que come, bebe o fuma puede afectarla a usted y a su bebe. No se debe usar alcohol ni tabaco durante el embarazo. Tambien es aconsejable no usar ningun remedio (con o ...

June 2008

116.

ACOG Releases New Recommendations on the Management of Asthma During Pregnancy

Washington, DC -- Pregnant asthmatic women should continue to use their asthma medication in the lowest dose possible to manage symptoms during pregnancy, according to a new Practice Bulletin release...

February 2008

117.

Intraperitoneal Chemotherapy for Ovarian Cancer

Number 396

(Reaffirmed 2010 )

ABSTRACT: Postoperative intravenous (IV) chemotherapy for advanced stage ovarian cancer has been the standard treatment. Recent studies have found significant survival advantages with the use of adju...

January 2008

PDF Download
118.

Subclinical Hypothyroidism in Pregnancy

Number 381

(Reaffirmed 2012)

ABSTRACT: Subclinical hypothyroidism is diagnosed in asymptomatic women when the thyroid-stimulating hormone level is elevated and the free thyroxine level is within the reference range. Thyroid horm...

October 2007

PDF Download
119.

Terapia hormonal

SP066

Durante la menopausia, el cuerpo de la mujer produce menos estrogeno y esta deja de tener la menstruacion. La menopausia es una etapa natural en la vida de una mujer. La falta de estrogeno puede indu...

September 2007

120.

ACOG Issues Guidelines for Research Involving Women

Washington, DC -- The American College of Obstetricians and Gynecologists (ACOG) today reiterated its position on the critical importance of including women in research trials. In a committee opinion...

August 2007

121.

Nalbuphine Hydrochloride Use for Intrapartum Analgesia

Number 376

(Reaffirmed 2012)

ABSTRACT: Safety concerns have been raised regarding the use of nalbuphine hydrochloride during labor. The American College of Obstetricians and Gynecologists finds data are insufficient to recommend...

August 2007

PDF Download
122.

Brand Versus Generic Oral Contraceptives

Number 375

(Reaffirmed 2010)

ABSTRACT:The U.S. Food and Drug Administration considers generic and brand name oral contraceptive (OC) products clinically equivalent and interchangeable. The American College of Obstetricians and G...

August 2007

PDF Download
123.

ACOG Issues New Opinion on Brand vs. Generic Oral Contraceptives

Washington, DC -- A woman should be able to request and obtain the oral contraceptive that she and her doctor decide best addresses her individual needs, according to a new committee opinion released...

July 2007

124.

ACOG Issues Recommendations on Prevention of Blood Clots in Gynecologic Surgery Patients

Washington, DC -- Blood clots are a leading cause of disability and death in patients following surgery, despite medical advances in their prevention, diagnosis, and treatment. The American College o...

July 2007

125.

Patents Medicine and the Interests of Patients

Number 364

(Reaffirmed 2009)

ABSTRACT: Many basic scientists and clinicians support the right to obtain and enforce patents on drugs, diagnostic tests, medical devices, and most recently, genes. Although those who develop useful...

May 2007

PDF Download
Advertisement